IGF1 and peripheral arterial disease: For instance, there were five traits with evidence to support an effect on liability to type 2 diabetes (whole-body fat-free mass, whole-body water mass, peak expiratory flow, lymphocyte count, IGF-1) but not liability to coronary or peripheral artery disease, as well as 12 and eight traits with specific effects on liability to coronary and peripheral artery disease, respectively.